Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |